All Pharma News
MTX110 Phase 1 Data Shows Increased Survival In DMG Brain Cancer

MTX110 Phase 1 Data Shows Increased Survival In DMG Brain Cancer
GLOBENEWSWIRE
02 Jul 2024
Share Share
Biodexa Announces Phase 2 Results of eRapa™ in Familial Adenomatous Polyposis

Biodexa Announces Phase 2 Results of eRapa™ in Familial Adenomatous Polyposis
GLOBENEWSWIRE
24 Jun 2024
Share Share
Results of Annual General Meeting

Results of Annual General Meeting
GLOBENEWSWIRE
13 Jun 2024
Share Share
eRapa FAP Phase 2 Data To Be Presented At InSIGHT 2024 In Barcelona

eRapa FAP Phase 2 Data To Be Presented At InSIGHT 2024 In Barcelona
GLOBENEWSWIRE
10 Jun 2024
Share Share
Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises

Biodexa Announces $7 Million of Gross Proceeds from Warrant Exercises
GLOBENEWSWIRE
22 May 2024
Share Share
Biodexa`s eRapa Shows Positive Phase 2 FAP Data At DDW 2024

Biodexa`s eRapa Shows Positive Phase 2 FAP Data At DDW 2024
GLOBENEWSWIRE
21 May 2024
Share Share
Posting of Annual Report & Notice of AGM - Total Voting Rights

Posting of Annual Report & Notice of AGM - Total Voting Rights
GLOBENEWSWIRE
15 May 2024
Share Share
Biodexa Licenses Phase 3 Asset eRapa„ for FAP Treatment

Biodexa Licenses Phase 3 Asset eRapa„ for FAP Treatment
GLOBENEWSWIRE
26 Apr 2024
Share Share
Preliminary Results for the Year Ended 31 December 2023

Preliminary Results for the Year Ended 31 December 2023
GLOBENEWSWIRE
19 Apr 2024
Share Share
Biodexa Announces Positive Ph I Trial Results for Diffuse Midline Glioma

Biodexa Announces Positive Ph I Trial Results for Diffuse Midline Glioma
GLOBENEWSWIRE
23 Feb 2024
Share Share